InBioGen Co Ltd (101140) — Cash Flow Quality Index
InBioGen Co Ltd (101140) has a Cash Flow Quality Index of -0.20x as of September 2025. Operating cash flow of ₩-1.67 Billion is below net income of ₩8.17 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 101140 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
InBioGen Co Ltd Cash Flow Quality Index (2018–2024)
Historical Cash Flow Quality Index for InBioGen Co Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check InBioGen Co Ltd (101140) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for InBioGen Co Ltd (2018–2024)
Year-by-year earnings quality comparison for InBioGen Co Ltd. For live market cap and the full company financial profile, see 101140 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | ₩-33.13 Million | ₩16.12 Billion | ▲ +97.8% |
| 2023 | -0.09x | ₩-1.05 Billion | ₩11.34 Billion | ▼ -23.3% |
| 2021 | -0.08x | ₩-7.07 Billion | ₩94.12 Billion | ▲ +74.3% |
| 2019 | -0.29x | ₩-3.83 Billion | ₩13.12 Billion | ▲ +71.4% |
| 2018 | -1.02x | ₩-1.70 Billion | ₩1.66 Billion | — |